🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › Maryland › Baltimore

Qorannoo klinikaalii Myelofibrosis Baltimore, MD keessatti

Qorannoo 7 Myelofibrosis f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06398457

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Maryland, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins University, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • John Hopkins Hospital, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins Hospital, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · Miili 8 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 3
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06479135

Qorannoo Myelofibrosis magaalota biroo keessatti

Qorannoo biroo Baltimore keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.